Stockscreener 앱 받기
1.04
3.70%
-0.04
전일 마감가:
$1.08
열려 있는:
$1.06
하루 거래량:
347.22K
Relative Volume:
1.02
시가총액:
$16.13M
수익:
-
순이익/손실:
$-7.51M
주가수익비율:
-0.7879
EPS:
-1.32
순현금흐름:
$-8.02M
1주 성능:
-3.70%
1개월 성능:
-0.95%
6개월 성능:
-22.39%
1년 성능:
-34.18%
1일 변동 폭
$1.03
$1.09
1주일 범위
$1.01
$1.12
52주 변동 폭
$0.6554
$2.115
Hoth Therapeutics Inc Stock (HOTH) Company Profile
명칭
Hoth Therapeutics Inc
전화
(646)756-2997
주소
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.04 | 16.76M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-15 | 개시 | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc 주식(HOTH)의 최신 뉴스
Hoth Therapeutics highlights obesity and pipeline progress to regulators - TipRanks
Hoth Therapeutics, Inc. Presents New Drug Development Initiatives - TradingView — Track All Markets
Hoth Therapeutics receives positive EU regulatory decision for cancer trial By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Cancer trial to test topical drug for skin side effects from therapy - Stock Titan
Hoth Therapeutics receives positive EU regulatory decision for cancer trial - Investing.com
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation - PR Newswire
Is Hoth Therapeutics Inc stock trending bullishPortfolio Performance Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Published on: 2026-01-14 02:28:37 - baoquankhu1.vn
Gap Down: What Wall Street predicts for Hoth Therapeutics Inc stock priceJuly 2025 Technicals & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Growth Value: Is Hoth Therapeutics Inc. stock supported by innovation pipelineEarnings Growth Report & Risk Managed Investment Signals - Улправда
Big Money Moves: Why Hoth Therapeutics Inc. stock could outperform in 2025Trade Analysis Summary & Fast Momentum Stock Entry Tips - ulpravda.ru
Why Hoth Therapeutics Inc. stock remains resilient2025 Momentum Check & Free Long-Term Investment Growth Plans - Улправда
Can Hoth Therapeutics Inc. stock weather global recessionWeekly Stock Report & Risk Controlled Daily Plans - Улправда
Will Hoth Therapeutics Inc. stock beat EPS estimatesJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - Улправда
Why Hoth Therapeutics Inc. stock could outperform in 2025Quarterly Performance Summary & Detailed Earnings Play Alerts - Улправда
Volume Summary: Why Hoth Therapeutics Inc. stock could outperform in 2025Portfolio Return Report & Safe Capital Growth Tips - Улправда
Hoth Therapeutics Files Dual U.S. Provisional Patents to Expand Oncology Dermatology IP - Digital Health News
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform - Nasdaq
Hoth Therapeutics Files Two US Provisional Patents for Oncology-Focused Dermatology Platform; Shares Rise - marketscreener.com
Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform - Contract Pharma
Hoth therapeutics files patents for oncology skin toxicity treatments By Investing.com - Investing.com Canada
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments - Investing.com Nigeria
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments By Investing.com - Investing.com South Africa
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform - PR Newswire
Hoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s Excited - MSN
Hoth Therapeutics (NASDAQ:HOTH) Stock Price Down 2.9% – Here’s What Happened - Defense World
Why Hoth Therapeutics Inc. stock remains undervaluedTrade Signal Summary & Precise Buy Zone Identification - DonanımHaber
Is Hoth Therapeutics Inc. stock trading near support levelsJuly 2025 Retail & Weekly Return Optimization Alerts - Улправда
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Aug Highlights: Is Hoth Therapeutics Inc stock gaining market shareWeekly Profit Report & Long-Term Capital Growth Strategies - moha.gov.vn
Sentiment Review: Why Hoth Therapeutics Inc stock remains undervaluedJuly 2025 EndofMonth & Safe Entry Zone Tips - moha.gov.vn
Published on: 2025-12-10 00:57:10 - moha.gov.vn
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal - ts2.tech
Hoth Therapeutics (HOTH) Price Target Increased by 12.50% to 4.59 - Nasdaq
D. Boral Capital Maintains Hoth Therapeutics (HOTH) Buy Recommendation - Nasdaq
Hoth Therapeutics stock rises after pipeline update By Investing.com - Investing.com India
Hoth Therapeutics stock rises after pipeline update - Investing.com
Hoth Therapeutics, Inc. Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated Ht-Kit, Advancing Ht-001 Phase 2, and New Gdnf Metabolic Program - MarketScreener
Hoth Therapeutics advances pipeline with four clinical programs By Investing.com - Investing.com India
Hoth Therapeutics advances pipeline with four clinical programs - Investing.com
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program - PR Newswire
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 - Eastern Progress
Institution Moves: Is Hoth Therapeutics Inc. stock trading near support levelsTrade Analysis Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Wall Street analysts’ outlook for Hoth Therapeutics Inc (HOTH) - Setenews
What technical signals suggest for Hoth Therapeutics Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research By Investing.com - Investing.com Nigeria
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research - Investing.com
Hoth Therapeutics accepted into Nvidia Connect Program, expanding its AI and accelerated computing capabilities - MarketScreener
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities - PR Newswire
Hoth Therapeutics Inc (HOTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):